Dunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies : vimarsana.com

Dunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies

/PRNewswire/ -- Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , America , Oskar Slotboom , Elizabeth Roper , George Underwood , Diana Kraskouskaya , Sylvie Berrebi , Novartis , Dunad Therapeutics , Epidarex Capital , Biogeneration Ventures , General Partner , Patrick Gunning , Chief Executive Officer , Chief Scientific Officer , Chief Operating Officer , North America , Mark Swallow Phd ,